A study of urinary myo-inositol as a sensitive marker of glucose intolerance
Background: We assessed the possibility of using myo-inositol as a marker of glucose intolerance. Methods: We measured urinary myo-inositol enzymatically before and 2 h after a 75-g oral glucose tolerance test in 564 volunteers, who were divided into four groups [normal glucose tolerance (NGT), impa...
Saved in:
Published in | Clinica chimica acta Vol. 344; no. 1; pp. 181 - 188 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.06.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: We assessed the possibility of using
myo-inositol as a marker of glucose intolerance.
Methods: We measured urinary
myo-inositol enzymatically before and 2 h after a 75-g oral glucose tolerance test in 564 volunteers, who were divided into four groups [normal glucose tolerance (NGT), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and diabetes mellitus (DM)]. Furthermore, we classified NGT into NGT-A (2-h blood glucose <120 mg/dl and 2-h glucosuria <50 mg/dl) and NGT-B (remaining NGT subjects). We then compared Δ
myo-inositol (
myo-inositol/creatinine ratio: 2-h after glucose load—before load) of each group to investigate the relationship between glucose intolerance and Δ
myo-inositol.
Results: The glucose tolerance of NGT-B appeared to have deteriorated compared with NGT-A as determined by blood glucose, insulin, and glucosuria. There was very little effect of gender or age on Δ
myo-inositol in NGT-A. Δ
myo-inositol was significantly higher than that in NGT-A (0.5±7.1 mg/g Cr) not only in IFG (8.7±19.5 mg/g Cr,
P<0.0001), IGT (14.8±22.9 mg/g Cr,
P<0.0001) and DM (79.5±37.1 mg/g Cr,
P<0.0001), but in NGT-B (7.4±12.7 mg/g Cr,
P<0.0001). With 2 mg/g Cr as a tentative cut-off for Δ
myo-inositol to detect NGT-A, sensitivity and specificity were 68% and 72%, respectively.
Conclusions: The Δ
myo-inositol can be use of a non-invasive and sensitive marker for glucose intolerance. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/j.cccn.2004.02.026 |